SKIN REVITALISATION

Face and neck revitalisation with platelet-rich plasma.

In this case series of 23 patients, the authors evaluated if there are real outcomes, benefits and side effects following a standardised PRP injection protocol DGS was calculated by comparing the spider improvement score, the pre- and post-improvement photographs, the patient’s satisfation score and the doctor’s satisfaction score.. Patients received a RegenPRP injection once a month for three months. Patients were evaluated one month after the last injection. Adefinitive graduated score (DGS) was calculated for each patient.

• The authors concluded that face and neck revitalisation with RegenPRP is a promising, easy-to-use technique, performing favourably in all small skin wrinkles, as well as in skin texture and elasticity assessments.

Figure 2: Graph illustrating the persent of patients scored for definitive graduated score. DGS score was good (average 12.8).

REFERENCE

5 Redaelli, A., D. Romano, and A. Marciano, Face and neck revitalisation with platelet-rich plasma (PRP): clinical outcome in a series of 23 consecutively treated patients. J Drugs Dermatol, 2010. 9(5): p. 466-72.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.